SGAM
Smith Group Asset Management Portfolio holdings
AUM
$1.53B
1-Year Return
38.67%
This Quarter Return
+31.89%
1 Year Return
+38.67%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$1.81B
AUM Growth
-$18.2M
(-0.99%)
Cap. Flow
-$453M
Cap. Flow
% of AUM
-24.96%
Top 10 Holdings %
Top 10 Hldgs %
40.04%
Holding
396
New
38
Increased
53
Reduced
183
Closed
98
Top Buys
| 1 |
Hologic
HOLX
|
$28M |
| 2 |
Parker-Hannifin
PH
|
$23.7M |
| 3 |
Ameriprise Financial
AMP
|
$18.5M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$12.9M |
| 5 |
Lowe's Companies
LOW
|
$12.9M |
Top Sells
| 1 |
Apple
AAPL
|
$57.1M |
| 2 |
Microsoft
MSFT
|
$51M |
| 3 |
Biogen
BIIB
|
$36M |
| 4 |
Amazon
AMZN
|
$33.9M |
| 5 |
Burlington
BURL
|
$25.3M |
Sector Composition
| 1 | Technology | 38.49% |
| 2 | Healthcare | 16.85% |
| 3 | Consumer Discretionary | 12.94% |
| 4 | Communication Services | 8.43% |
| 5 | Industrials | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Preferred Bank
PFBC
$1.18B
| $151K | 0.01% |
3,520
-50
| -1% | -$2.15K |
|
|
BPMC
177
DELISTED
Blueprint Medicines
BPMC
| $145K | 0.01% |
1,860
-30
| -2% | -$2.34K |
|
|
FBM
178
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
| $145K | 0.01% |
9,300
-140
| -1% | -$2.18K |
|
179
Arrowhead Research
ARWR
$4.02B
| $143K | 0.01% |
3,310
-50
| -1% | -$2.16K |
|
180
FTI Consulting
FCN
$5.46B
| $142K | 0.01% |
1,240
-30
| -2% | -$3.44K |
|
181
Halozyme
HALO
$8.76B
| $142K | 0.01% |
5,290
-60
| -1% | -$1.61K |
|
182
Emergent Biosolutions
EBS
$404M
| $139K | 0.01% |
1,760
-30
| -2% | -$2.37K |
|
|
XLRN
183
DELISTED
Acceleron Pharma Inc.
XLRN
| $129K | 0.01% |
1,350
-20
| -1% | -$1.91K |
|
184
Select Medical
SEM
$1.62B
| $127K | 0.01% |
15,962
-148
| -0.9% | -$1.18K |
|
|
GBT
185
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $124K | 0.01% |
1,970
-30
| -2% | -$1.89K |
|
186
Amicus Therapeutics
FOLD
$2.46B
| $123K | 0.01% |
8,180
-100
| -1% | -$1.5K |
|
187
CVR Energy
CVI
$3.16B
| $117K | 0.01% |
5,834
-70
| -1% | -$1.4K |
|
188
Iovance Biotherapeutics
IOVA
$901M
| $114K | 0.01% |
4,150
-40
| -1% | -$1.1K |
|
189
PTC Therapeutics
PTCT
$4.55B
| $110K | 0.01% |
2,170
-30
| -1% | -$1.52K |
|
190
Sanmina
SANM
$6.44B
| $109K | 0.01% |
4,350
-50
| -1% | -$1.25K |
|
191
Natera
NTRA
$23.1B
| $108K | 0.01% |
2,170
-30
| -1% | -$1.49K |
|
|
MRTX
192
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $106K | 0.01% |
930
-20
| -2% | -$2.28K |
|
193
Berkshire Hathaway Class B
BRK.B
$1.08T
| $105K | 0.01% |
589
-3
| -0.5% | -$535 |
|
|
NVTA
194
DELISTED
Invitae Corporation
NVTA
| $104K | 0.01% |
3,420
-40
| -1% | -$1.22K |
|
|
MNTA
195
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $104K | 0.01% |
3,120
-30
| -1% | -$1K |
|
196
FibroGen
FGEN
$48.9M
| $96K | 0.01% |
95
-1
| -1% | -$1.01K |
|
|
ARNA
197
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $91K | 0.01% |
1,450
-20
| -1% | -$1.26K |
|
198
Insmed
INSM
$30.7B
| $86K | ﹤0.01% |
3,110
-40
| -1% | -$1.11K |
|
|
BHVN
199
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $83K | ﹤0.01% |
1,140
-10
| -0.9% | -$728 |
|
200
CareDx
CDNA
$736M
| $58K | ﹤0.01% |
1,650
-30
| -2% | -$1.06K |
|